Log in to save to my catalogue

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6121718

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Somatic mutations in the isocitrate dehydrogenase 2 gene (
IDH2
) contribute to the pathogenesis of acute myeloid leukaemia (AML) through the production of the oncometabolite 2-hydroxyglutarate (2HG)
1

8
. Enasidenib (AG-221) is an allosteric inhibitor that binds to the IDH2 dimer interface and blocks the production of 2HG by ID...

Alternative Titles

Full title

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6121718

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6121718

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-018-0251-7

How to access this item